|
Volumn 795, Issue 2, 2003, Pages 273-289
|
Liquid chromatography-tandem mass spectrometric quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human peripheral blood mononuclear cells (PBMC): Practical approaches to PBMC preparation and PBMC assay design for high-throughput analysis
|
Author keywords
Atazanavir; Peripheral blood mononuclear cells
|
Indexed keywords
BIOASSAY;
BLOOD;
CALIBRATION;
CELLS;
COMPOSITION;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
QUALITY CONTROL;
BLOOD CELLS;
ENZYME KINETICS;
ATAZANAVIR;
PROTEINASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
AUTOMATION;
BLOOD SAMPLING;
CALIBRATION;
CELL ASSAY;
CELL COUNT;
CONTROLLED STUDY;
DEVICE;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
ION MONITORING;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETER;
MOLECULAR WEIGHT;
MONONUCLEAR CELL;
PRIORITY JOURNAL;
QUALITY CONTROL;
QUANTITATIVE ANALYSIS;
REPRODUCIBILITY;
ROOM TEMPERATURE;
SAMPLING;
SOLID PHASE EXTRACTION;
STANDARDIZATION;
STEREOCHEMISTRY;
SYNTHESIS;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
|
EID: 0141649213
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(03)00589-0 Document Type: Article |
Times cited : (44)
|
References (13)
|